Literature DB >> 9365122

Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.

J R White1, C Imburgia, E Dul, E Appelbaum, K O'Donnell, D J O'Shannessy, M Brawner, J Fornwald, J Adamou, N A Elshourbagy, K Kaiser, J J Foley, D B Schmidt, K Johanson, C Macphee, K Moores, D McNulty, G F Scott, R P Schleimer, H M Sarau.   

Abstract

Eotaxin has been found to bind exclusively to a single chemokine receptor, CCR3. Using expression sequence tag screening of an activated monocyte library, a second chemokine has been identified; it was expressed and purified from a Drosophila cell culture system and appears to only activate CCR3. Eotaxin-2, MPIF-2, or CKbeta-6, is a human CC chemokine with low amino acid sequence identity to other chemokines. Eotaxin-2 promotes chemotaxis and Ca2+ mobilization in human eosinophils but not in neutrophils or monocytes. Cross-desensitization calcium mobilization experiments using purified eosinophils indicate that eotaxin and MCP-4, but not RANTES, MIP-1alpha, or MCP-3, can completely cross-desensitize the calcium response to eotaxin-2 on these cells, indicating that eotaxin-2 shares the same receptor used by eotaxin and MCP-4. Eotaxin-2 was the most potent eosinophil chemoattractant of all the chemokines tested. Eotaxin-2 also displaced 125I-eotaxin bound to the cloned CCR3 stably expressed in CHO cells (CHO-CCR3) and to freshly isolated human eosinophils with affinities similar to eotaxin and MCP-4. 125I-Eotaxin-2 binds with high affinity to eosinophils and both eotaxin and cold eotaxin-2 displace the ligand with equal affinity. Eotaxin and eotaxin-2 promote a Ca2+ transient in RBL-2H3 cells stably transfected with CCR3 (RBL-2H3-CCR3) and both ligands cross-desensitized the response of the other but not the response to LTD4. The data indicate that eotaxin-2 is a potent eosinophil chemotactic chemokine exerting its activity solely through the CCR3 receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365122     DOI: 10.1002/jlb.62.5.667

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  33 in total

Review 1.  Eotaxin and asthma: some answers, more questions.

Authors:  C J Corrigan
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma.

Authors:  Shailendra R Singh; Nikol Sullo; Maria Matteis; Giuseppe Spaziano; John McDonald; Ruth Saunders; Lucy Woodman; Konrad Urbanek; Antonella De Angelis; Raffaele De Palma; Rachid Berair; Mitesh Pancholi; Vijay Mistry; Francesco Rossi; Remo Guerrini; Girolamo Calò; Bruno D'Agostino; Christopher E Brightling; David G Lambert
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

3.  Degranulating eosinophils in human endometriosis.

Authors:  R D Blumenthal; M Samoszuk; A P Taylor; G Brown; R Alisauskas; D M Goldenberg
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

4.  Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration.

Authors:  Ji-Won Min; June-Hyuk Lee; Choon-Sik Park; Hun Soo Chang; Tai Youn Rhim; Sung-Woo Park; An-Soo Jang; Hyoung-Doo Shin
Journal:  J Hum Genet       Date:  2005-03-03       Impact factor: 3.172

5.  Titanium oxide nanoparticle instillation induces inflammation and inhibits lung development in mice.

Authors:  Namasivayam Ambalavanan; Andrei Stanishevsky; Arlene Bulger; Brian Halloran; Chad Steele; Yogesh Vohra; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-07       Impact factor: 5.464

Review 6.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

7.  Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7).

Authors:  Xiao-Zhou Shang; Bo-Chin Chiu; Valerie Stolberg; Nicholas W Lukacs; Steven L Kunkel; Hedwig S Murphy; Stephen W Chensue
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

8.  Chemotaxis of bone marrow derived eosinophils in vivo: a novel method to explore receptor-dependent trafficking in the mouse.

Authors:  Eva M Sturm; Kimberly D Dyer; Caroline M Percopo; Akos Heinemann; Helene F Rosenberg
Journal:  Eur J Immunol       Date:  2013-06-14       Impact factor: 5.532

9.  Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction.

Authors:  Takayuki Ishii; Tomoyuki Fujita; Takashi Matsushita; Koichi Yanaba; Minoru Hasegawa; Hiroko Nakashima; Fumihide Ogawa; Kazuhiro Shimizu; Kazuhiko Takehara; Thomas F Tedder; Shinichi Sato; Manabu Fujimoto
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

10.  Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3-deficient mice.

Authors:  Derek A Wainwright; Junping Xin; Nichole A Mesnard; Taylor R Beahrs; Christine M Politis; Virginia M Sanders; Kathryn J Jones
Journal:  ASN Neuro       Date:  2009-12-11       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.